RETRACTED ARTICLE: New insight of the efficacy trimetazidine in patients with peripheral arterial disease: a meta-analysis

期刊论文
出版模式：

开放获取
发表日期：

2024年3月6日

查看全文

Ketut Angga Aditya Putra Pramana,
Ni Gusti Ayu Made Sintya Dwi Cahyani,
Yusra Pintaningrum,
Basuki Rahmat

摘要

Background

This review aims to examine the impact of trimetazidine on skeletal muscle function in patients suffering from peripheral artery disease (PAD).

Methods

We searched for studies, both experimental and observational research, concerning the comparison of trimetazidine administration to placebo/standard of care in patients with PAD in PubMed, ScienceDirect, and Cochrane. Meta-analyses of the included studies were performed using Review Manager v5.4. Clinical parameters [ankle-brachial index (ABI) and maximum walking distance (MWD)] were analyzed.

Results

Three observational studies involving 378 participants with PAD satisfied predefined criteria. There was no substantial difference between the examined groups’ on ABI (pre- and post-intervention) (MD = − 0.06 [− 0.19 to 0.07], p = 0.38, I² = 90%). Meanwhile, MWD improvement was significantly higher (MD = 14.15 [6.05–22.25], p = 0.0006, I² = 37%) in trimetazidine group than in the control group.

Conclusions

Current evidence from our meta-analysis suggests the beneficial role of trimetazidine's anti-ischemic effect in PAD patients by improving MWD, while it has an insignificant influence on ABI.